Recent Advances in Radiofrequency Ablation for the Management of Hepatocellular Carcinoma

Authors

Takashi Himoto1,*, Kazutaka Kurokohchi2, Seishiro Watanabe3, Tsutomu Masaki2
1Department of Integrated Medicine, [email protected], Japan
2Department of Gastroenterology and Neurology, School of Medicine, Kagawa University, Japan
3Department of Internal Medicine, Kagawa Prefectural Central Hospital, Japan
*Corresponding Author: Department of Integrated Medicine, Kagawa University School of Medicine, 1750-1, Ikenobe, Miki-Cho, Kita-Gun, Kagawa 761-0793, [email protected], Japan. Tel: +81-878912349. Fax: +81-878644631. Email: [email protected]

Hepatitis Monthly:Vol. 12, issue 10; 5945
Published online:Oct 10, 2012
Article type:Review Article
Received:Jul 31, 2011
Accepted:Jan 09, 2012
How to Cite:Himoto T, Kurokohchi K, Watanabe S, Masaki T. Recent Advances in Radiofrequency Ablation for the Management of Hepatocellular Carcinoma. Hepat Mon. 2012;12(10):5945. doi: https://doi.org/10.5812/hepatmon.5945

Abstract

Contexts:

Hepatocellular carcinoma (HCC) is one of the most common malignant diseases in the world. Because less than 20% of patients with HCC are resectable, various types of non-surgical treatment have been developed.

Evidence Acquisition:

At present, radiofrequency ablation (RFA) is accepted as the standard local treatment for patients with HCC because of its superior local control and overall survival compared to other local treatments.

Results:

New devices for RFA and combination treatments of RFA with other procedures have been developed to improve anti-tumoral effects.

Conclusions:

This review mainly focuses on the status of RFA in the management of HCC and recent advances in RFA treatment technology.

Highlights

Full Text

Full text is available in PDF

Copyright

© 2012, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

11
Jun
2018
Radiofrequency and Microwave Ablation in the Treatment of Hepatocellular Carcinoma

Radiofrequency and Microwave Ablation in the Treatment of Hepatocellular Carcinoma

Ibrahim Halil Sever,
Metin Sucu,
Erhan Biyikli

Sever IH, Sucu M, Biyikli E. Radiofrequency and Microwave Ablation in the Treatment of Hepatocellular Carcinoma. I J Radiol. 2018;15(3):e62396. doi: https://doi.org/10.5812/iranjradiol.62396

4
Oct
2016

Outcomes of Transarterial Chemoembolization With or Without Additional Radiofrequency Ablation in Hepatocellular Carcinoma of 2 to 5 cm in Diameter

Mi-Young Kim,
Jin Woong Kim,
Dae-Seong Myung,
Chung-Hwan Jun,
Wan-Sik Lee,
Yang Jun Kang
,et al.

Kim M, Kim JW, Myung D, Jun C, Lee W, et al. Outcomes of Transarterial Chemoembolization With or Without Additional Radiofrequency Ablation in Hepatocellular Carcinoma of 2 to 5 cm in Diameter. I J Radiol. 2017;14(1):e13484. doi: https://doi.org/10.5812/iranjradiol.39515

19
Nov
2012

Imaging and Imaging-Guided Interventions in the Diagnosis and Management of Hepatocellular Carcinoma (HCC)-Review of Evidence

Hossein Ghanaati,
Seyed Moayed Alavian,
Ali Jafarian,
Nasser Ebrahimi Daryani,
Mohsen Nassiri-Toosi,
Amir Hossein Jalali
,et al.

Ghanaati H, Alavian SM, Jafarian A, Ebrahimi Daryani N, Nassiri-Toosi M, et al. Imaging and Imaging-Guided Interventions in the Diagnosis and Management of Hepatocellular Carcinoma (HCC)-Review of Evidence. I J Radiol. 2012;9(4):. doi: https://doi.org/10.5812/iranjradiol.8242

30
Jun
2006

Radiofrequency Ablation of Liver Tumors: The First Preliminary Report in Iran

Shahram Akhlaghpour

Akhlaghpour S. Radiofrequency Ablation of Liver Tumors: The First Preliminary Report in Iran. I J Radiol. 2006;3(3):e79004. doi:

30
Apr
2019
Assessment of Treatment Efficacy Immediately After Combined Therapy of Ultrasound-Guided Radiofrequency Ablation and Conventional Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: Comparison Between Multidetector-Row CT and MRI

Assessment of Treatment Efficacy Immediately After Combined Therapy of Ultrasound-Guided Radiofrequency Ablation and Conventional Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: Comparison Between Multidetector-Row CT and MRI

Sung Mo Kim,
Sang Soo Shin,
Byung Chan Lee,
Jin Woong Kim,
Suk Hee Heo,
Chung Hwan Jun
,et al.

Kim SM, Shin SS, Lee BC, Kim JW, Heo SH, et al. Assessment of Treatment Efficacy Immediately After Combined Therapy of Ultrasound-Guided Radiofrequency Ablation and Conventional Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: Comparison Between Multidetector-Row CT and MRI. I J Radiol. 2019;16(2):e80926. doi: https://doi.org/10.5812/iranjradiol.80926

More by these authors

Takashi HimotoPubMedScholar
Kazutaka KurokohchiPubMedScholar
Seishiro WatanabePubMedScholar
Tsutomu MasakiPubMedScholar
Share
Cited by
Metrics